High-dose cyclophosphamide without stem cell rescue for the treatment of refractory Behcet's disease.

TitleHigh-dose cyclophosphamide without stem cell rescue for the treatment of refractory Behcet's disease.
Publication TypeJournal Article
Year of Publication2011
AuthorsHenderson CF, Brodsky RA, Jones RJ, Levine SM
JournalSeminars in arthritis and rheumatism
Volume41
Issue2
Pagination301-4
Date Published2011 Oct
Abstract

Behcet's disease (BD) is a systemic inflammatory disorder characterized by recurrent mucocutaneous ulcerations, ocular inflammation, and numerous severe systemic inflammatory manifestations. While most patients respond to standard immunosuppressive therapies, a subset will develop refractory disease. In this report, the use of a novel therapy for the treatment of BD is described.

DOI10.1016/j.jtcvs.2011.06.027
Alternate JournalSemin. Arthritis Rheum.